Dolutegravir sodium

CAS: 1051375-19-9

Ref. 3D-BSB37519

Produktinformation

• Name: Dolutegravir sodium
• Synonyme: 2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, sodium salt, 2H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, sodium salt (1:1), (4R,12aS)-, Gsk 1349572A
• CAS: 1051375-19-9

Beschreibung

Dolutegravir is an antiviral agent that blocks the HIV reverse transcriptase enzyme, which is necessary for viral replication. It is a sodium salt that has been shown to be active against a number of other viruses in vitro, including herpes simplex virus type 1 and 2 (HSV-1 and HSV-2), human cytomegalovirus (HCMV), varicella zoster virus (VZV), and hepatitis B virus. Dolutegravir inhibits the growth of bacteria by binding to the 50S ribosomal subunit. It binds with high affinity to human serum proteins and as a result may have long-term toxicity effects on the liver. The drug also has potential for drug interactions with other drugs that are substrates or inhibitors of CYP3A4/5 enzymes.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 442.40 g/mol
• Formel: C₂₀H₁₉F₂N₃NaO₅
• Reinheit: Min. 98.5 Area-%
• Farbe/Form: Powder